OCA
INZY

Octagon Capital Advisors’s Inozyme Pharma INZY Stock Holding History

Octagon Capital Advisors’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400,000
Closed -$1.7M – 59
2023
Q4 		$1.7M Sell
400,000
-900,000
-69% -$3.83M 0.27% 28
2023
Q3 		$5.46M Buy
1,300,000
+1,250,298
+2,516% +$5.25M 0.84% 22
2023
Q2 		$277K Buy
+49,702
New +$277K 0.04% 39